Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Toxicologic pathology is transitioning from analog to digital methods. This transition seems inevitable due to a host of ongoing social and medical technological forces. Of these, artificial intelligence (AI) and in particular machine learning (ML) are globally disruptive, rapidly growing sectors of technology whose impact on the long-established field of histopathology is quickly being realized. The development of increasing numbers of algorithms, peering ever deeper into the histopathological space, has demonstrated to the scientific community that AI pathology platforms are now poised to truly impact the future of precision and personalized medicine. However, as with all great technological advances, there are implementation and adoption challenges. This review aims to define common and relevant AI and ML terminology, describe data generation and interpretation, outline current and potential future business cases, discuss validation and regulatory hurdles, and most importantly, propose how overcoming the challenges of this burgeoning technology may shape toxicologic pathology for years to come, enabling pathologists to contribute even more effectively to answering scientific questions and solving global health issues. [Box: see text]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the impact of AI on the long-established field of histopathology needs to be further defined when the data generated are used for regulatory purposes (Turner et al. 2020).”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as Turner et al. 2020
Citations
Cites
ImageNet classification with deep convolutional neural networks
Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2017) · Communications of the ACM · doi:10.1145/3065386 · Cited by 112,155
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
(2008) · Journal of Machine Learning Research · Cited by 33,051
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization
Selvaraju, R. R., Cogswell, M., Das, A., Vedantam, R., Parikh, D., & Batra, D. (2017) · 2017 IEEE International Conference on Computer Vision (ICCV) · doi:10.1109/iccv.2017.74 · Cited by 24,513
A survey on deep learning in medical image analysis
Litjens, G., Kooi, T., Bejnordi, B. E., Setio, A. A. A., Ciompi, F., Ghafoorian, M., van der Laak, J. A. W. M., van Ginneken, B., & Sánchez, C. I. (2017) · Medical Image Analysis · doi:10.1016/j.media.2017.07.005 · Cited by 15,332
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Deep Learning: Methods and Applications
Deng, L., & Yu, D. (2014) · Foundations and Trends® in Signal Processing · doi:10.1561/2000000039 · Cited by 3,480
Ehteshami Bejnordi, B., Veta, M., Johannes van Diest, P., van Ginneken, B., Karssemeijer, N., Litjens, G., van der Laak, J. A. W. M., and the CAMELYON16 Consortium, Hermsen, M., Manson, Q. F., et al. (2017) · JAMA · doi:10.1001/jama.2017.14585 · Cited by 3,293
Deep neural networks are easily fooled: High confidence predictions for unrecognizable images
Nguyen, A., Yosinski, J., & Clune, J. (2015) · 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2015.7298640 · Cited by 3,258
Research works printed but not linked: 21
- Ciresan D, Giusti A, Gambardella LM, Schmidhuber J. Deep Neural Networks Segment Neuronal Membranes In Electron Microscopy Images. Neural Information Processing Systems; 2012. https://papers.nips.cc/paper/4741-deep-neural-networks-segment-neuronal-membranes-in-electron-microscopy-images. Accessed October 2, 2019.
- Ciresan DC, 2013, Med Image Comput Comput Assist Interv, 16, 411
- Gibney E, Nature
- Mthembu L, Fifteenth Annual Symposium of the Pattern Recognition Association of South Africa, 2004
- Mthembu L, Marwala T. A note on the separability index. 2008. https://arxiv.org/abs/0812.1107. Accessed April 5, 2019. · arXiv
- Greene JR. Feature subset selection using Thornton’s separability index and its applicability to a number of sparse proximity-based classifiers. 2001. https://pdfs.semanticscholar.org/dacc/c51597af27682033bcdae55097d3faea7864.pdf. Accessed October 2, 2019.
- Fawcett T, 2004, Mach Learn, 1
- Chollet F, 2017, Deep Learning With Python
- van der Maaten LJP, 2008, J Mach Learn Res, 9, 2579
- McInnes L, 2018, ArXiv
- Ren J, 2015, IEEE Eng Med Bio, 2015, 3013
- Couture HD, 2018, NPJ Breast Cancer, 3, 4
- Schaumberg AJ, 2017, BioRxiv, 064279
- Rao S. MITOS-RCNN: a novel approach to mitotic figure detection in breast cancer histopathology images using region based convolutional neural networks. arXiv:1807.01788. https://arxiv.org/abs/1807.01788. Accessed October 2, 2019. · arXiv
- Komura D, 2018, biorxiv
- Otalora S, 2018, bioRxiv
- Pfizer. IBM and Pfizer to accelerate immuno-oncology research with Watson for drug discovery. 2016. https://www.pfizer.com/news/press-release/press-release-detail/ibm_and_pfizer_to_accelerate_immuno_oncology_research_with_watson_for_drug_discovery. Accessed August 5, 2019.
- Hipp JD, 2018, Proceedings of the American Association for Cancer Research Annual Meeting
- Solberg BL, 2012, Clin Lab Sci, 25
- Crowley RS, 2001, Proc AMIA Symp, 125
- Oxford. Essential Quotations: Roy Amara. Oxford, England: Oxford University Press. 2016. http://www.oxfordreference.com/view/10.1093/acref/9780191826719.001.0001/q-oro-ed4-00018679. Accessed April 05, 2019, 2019. · doi:10.1093/acref/9780191826719.001.0001/q-oro-ed4-00018679
Cited by
The use of artificial intelligence, machine learning and deep learning in oncologic histopathology
Sultan, A. S., Elgharib, M. A., Tavares, T., Jessri, M., & Basile, J. R. (2020) · Journal of Oral Pathology & Medicine · doi:10.1111/jop.13042 · Cited by 176
Żuraw, A., & Aeffner, F. (2021) · Veterinary Pathology · doi:10.1177/03009858211040484 · Cited by 120
Self-citationAI'S Healing Touch: Examining Machine Learning's Transformative Effects On Healthcare
Husnain, A., Rasool, S., Saeed, A., Gill, A. Y., & Hussain, H. K. (2023) · Journal Of World Science · doi:10.58344/jws.v2i10.448 · Cited by 67
Mehrvar, S., Himmel, L. E., Babburi, P., Goldberg, A. L., Guffroy, M., Janardhan, K. S., Krempley, A. L., & Bawa, B. (2021) · Journal of Pathology Informatics · doi:10.4103/jpi.jpi_36_21 · Cited by 49
Self-citationRamot, Y., Zandani, G., Madar, Z., Deshmukh, S., & Nyska, A. (2020) · Toxicologic Pathology · doi:10.1177/0192623320926478 · Cited by 43
Metadata
- Authors
- Turner, O. C., Aeffner, F., Bangari, D. S., High, W., Knight, B., Forest, T., Cossic, B., Himmel, L. E., Rudmann, D. G., Bawa, B., Muthuswamy, A., Aina, O. H., Edmondson, E. F., Saravanan, C., Brown, D. L., Sing, T., & Sebastian, M. M.
- Affiliations
- Novartis, Novartis Institutes for Biomedical Research, Preclinical Safety, East Hanover, NJ, USA
- Amgen (United States) (US)
- Sanofi, Global Discovery Pathology, Framingham, MA, USA
- High Preclinical Pathology Consulting, Rochester, NY, USA
- Boehringer Ingelheim (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- F. Hoffmann-La Roche AG (CH)
- Vanderbilt University Medical Center (US)
- Charles River Laboratories (United States) (US)
- AbbVie (United States) (US)
- Regeneron (United States) (US)
- National Institutes of Health (US)
- Novartis, Novartis Institutes for Biomedical Research, Preclinical Safety, Cambridge, MA, USA
- Novartis (Switzerland) (CH)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Turner, Oliver C.
- ORCID
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2019-10-23
- Volume
- 48
- Issue
- 2
- Pages
- 277-294
- ISSN
- 0192-6233 (ISSN-L)
- 1533-1601
- OpenAlex
- W2981553472
- Cited by
- 64
- References
- 148
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 6 · 2023: 8 · 2022: 5 · 2021: 16 · 2020: 10
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Toxicologic Pathology (publishedVersion)
- PubMed (publishedVersion)
- The Novartis Repository (Novartis) (submittedVersion)
- Topics
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- artificial intelligence, machine learning, digital pathology, histopathology, AI terminology, business case, validation, regulatory challenges, barriers to adoption, precision medicine
- MeSH terms
- Artificial Intelligence, Humans, Image Processing, Computer-Assisted, Pathology, Toxicology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology. https://app.cochat.ai/papers/10.1177/0192623319881401
- The paper
- Turner, O. C., Aeffner, F., Bangari, D. S., High, W., Knight, B., Forest, T., Cossic, B., Himmel, L. E., Rudmann, D. G., Bawa, B., Muthuswamy, A., Aina, O. H., Edmondson, E. F., Saravanan, C., Brown, D. L., Sing, T., & Sebastian, M. M. (2020). Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology. Toxicologic Pathology. https://doi.org/10.1177/0192623319881401
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.